.OS Therapies will specify on the NYSE American supply substitution this morning using a $6.4 millio...
.ALX Oncology's period 2 gastric cancer feedback rate has damaged. After seeing its own CD47 blocker...
.An Additional of Ionis Pharmaceuticals' vital midphase readouts has fallen short of assumptions, ur...
.While Biogen's pharma peers are actually looking for late-stage properties with little bit of risk,...
.Instil Bio has actually been actually a biotech trying to find a pipeline after it scrapped its own...
.Biogen has restored rights to a very early Alzheimer's ailment system to Denali Therapies, going ou...
.Welcome to this week's Chutes & Ladders, our roundup of considerable leadership hirings, shootin...
.Tip's attempt to manage an uncommon genetic health condition has actually attacked one more obstacl...
.Vir Biotechnology's second-quarter incomes record had not been short of huge news. The company welc...
.Galapagos has actually stopped briefly application in a trial of a BCMA-directed CAR-T cell treatme...